Conversely, Costa et al., reported that pharmacological inhibition of HO-1 contributes to a substantial reduction of MTB burden, implying that HO-1 plays a pathogenic role rather than a protective in TB (32). This evidence concerns the gene HMOX1 and tuberculosis.